Related Experiment Videos
[What future for intracranial angioplasty?]
Presse Medicale (Paris, France : 1983)
|November 12, 1998
Insights
Atheromatous stenosis of intracranial arteries causes ischemic events. Balloon angioplasty offers an 80% success rate for dilation, indicated for symptomatic patients unresponsive to anti-thrombotic therapy.
Area of Science:
- Neurology
- Vascular Medicine
- Interventional Cardiology
Background:
- Atheromatous stenosis of intracranial arteries is a primary cause of ischemic cerebral events.
- Current treatment primarily relies on medical management.
- Percutaneous balloon angioplasty is an emerging interventional option.
Discussion:
- Balloon angioplasty demonstrates an 80% success rate in dilating intracranial arterial stenosis.
- This endovascular technique is still under evaluation for widespread clinical adoption.
- It may be indicated for symptomatic patients who have failed medical management, specifically anti-thrombotic regimens.
Key Insights:
- Intracranial artery stenosis poses a significant risk for stroke.
- Percutaneous balloon angioplasty is a viable treatment option with high success rates.
- Patient selection is crucial, focusing on symptomatic individuals with treatment-resistant stenosis.
Outlook:
- Further clinical trials are needed to establish definitive guidelines for percutaneous balloon angioplasty.
- Long-term outcomes and safety profiles require continued investigation.
- This technique holds promise for improving outcomes in patients with severe intracranial stenosis.
Abstract:
Atheromatous stenosis of the intracranial arteries is a major cause of ischemic cerebral events. To date, treatment has been medical. Percutaneous balloon angioplasty can be used to dilate intracranial arterial stenosis with an 80% success rate. This technique is still under evaluation but can be indicated in symptomatic patients after failure of a well-conducted anti-thrombotic regimen.